Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia
Reports from University of Michigan describe recent advances in acute lymphoblastic leukemia in children
March 30th, 2008
Research findings, 'Children with hyperdiploid but not triple trisomy (+4,+10,+17) acute lymphoblastic leukemia have an increased incidence of extramedullary relapse on current therapies: a single institution experience,' are discussed in a new report. "To evaluate the outcome of children with high hyperdiploid acute lymphoblastic leukemia (hHDALL) treated at the author's institution. One hundred thirty-five consecutive children with B-precursor ALL were diagnosed between 1991 and 2002:38 (28.1%) hHDALL and 97 (71.9%) non-hHDALL," scientists writing in the American Journal of Hematology report. "In the hHDALL group, 11/38 (28.9%) relapsed at a median interval of...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-30)
|
